Nordea Investment Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.7M | Sell |
14,205
-50
| -0.4% | -$28.2K | 0.01% | 511 |
|
|
2026
Q1 | $8.28M | Buy |
14,255
+10,146
| +247% | +$5.05M | 0.01% | 484 |
|
|
2025
Q4 | $2.02M | Buy |
4,109
+3
| +0.1% | +$1.4K | ﹤0.01% | 749 |
|
|
2025
Q3 | $1.73M | Sell |
4,106
-6,808
| -62% | -$2.29M | ﹤0.01% | 759 |
|
|
2025
Q2 | $3.15M | Buy |
10,914
+3,664
| +51% | +$1.1M | ﹤0.01% | 648 |
|
|
2025
Q1 | $2.22M | Buy |
7,250
+3,872
| +115% | +$1.33M | ﹤0.01% | 680 |
|
|
2024
Q4 | $1.21M | Sell |
3,378
-75,464
| -96% | -$27.7M | ﹤0.01% | 778 |
|
|
2024
Q3 | $28.4M | Sell |
78,842
-189,674
| -71% | -$64.1M | 0.03% | 297 |
|
|
2024
Q2 | $86.2M | Sell |
268,516
-32,404
| -11% | -$8.58M | 0.1% | 217 |
|
|
2024
Q1 | $72.4M | Buy |
300,920
+262,222
| +678% | +$59.2M | 0.09% | 230 |
|
|
2023
Q4 | $8.43M | Buy |
38,698
+23,532
| +155% | +$5.42M | 0.01% | 428 |
|
|
2023
Q3 | $3.43M | Buy |
15,166
+12,553
| +480% | +$2.89M | ﹤0.01% | 589 |
|
|
2023
Q2 | $572K | Hold |
2,613
| – | – | ﹤0.01% | 894 |
|
|
2023
Q1 | $577K | Buy |
+2,613
| New | +$644K | ﹤0.01% | 884 |
|
|
2019
Q2 | – | Sell |
-1,113
| Closed | -$130K | – | 1277 |
|
|
2019
Q1 | $130K | Sell |
1,113
-10,600
| -90% | -$1.24M | ﹤0.01% | 1191 |
|
|
2018
Q4 | $1.27M | Hold |
11,713
| – | – | ﹤0.01% | 918 |
|
|
2018
Q3 | $1.5M | Sell |
11,713
-4,605
| -28% | -$570K | ﹤0.01% | 941 |
|
|
2018
Q2 | $1.85M | Buy |
16,318
+4,605
| +39% | +$506K | ﹤0.01% | 764 |
|
|
2018
Q1 | $1.32M | Buy |
11,713
+10,600
| +952% | +$1.35M | ﹤0.01% | 808 |
|
|
2017
Q4 | $165K | Hold |
1,113
| – | – | ﹤0.01% | 994 |
|
|
2017
Q3 | $130K | Hold |
1,113
| – | – | ﹤0.01% | 1000 |
|
|
2017
Q2 | $144K | Hold |
1,113
| – | – | ﹤0.01% | 1018 |
|
|
2017
Q1 | $151K | Sell |
1,113
-95
| -8% | -$14.4K | ﹤0.01% | 981 |
|
|
2016
Q4 | $173K | Hold |
1,208
| – | – | ﹤0.01% | 957 |
|
|
2016
Q3 | $143K | Hold |
1,208
| – | – | ﹤0.01% | 965 |
|
|
2016
Q2 | $128K | Buy |
1,208
+190
| +19% | +$21.2K | ﹤0.01% | 932 |
|
|
2016
Q1 | $113K | Hold |
1,018
| – | – | ﹤0.01% | 897 |
|
|
2015
Q4 | $159K | Hold |
1,018
| – | – | ﹤0.01% | 780 |
|
|
2015
Q3 | $134K | Hold |
1,018
| – | – | ﹤0.01% | 815 |
|
|
2015
Q2 | $177K | Buy |
+1,018
| New | +$183K | ﹤0.01% | 759 |
|
Other funds holding UTHR
ACA
JT
Nordea Investment Management's UTHR Position: Q2 2026 in Review
Nordea Investment Management reduced its United Therapeutics (UTHR) stake by 0.35% in Q2 2026, selling an estimated $28.2K and leaving 14,205 shares worth $7.7M. The position accounts for 0.01% of the portfolio, ranked #511.
Nordea Investment Management first reported a position in UTHR in Q2 2015 and has held it in 30 quarters since. The position peaked at $86.2M in Q2 2024. 879 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Nordea Investment Management held 14,205 shares of United Therapeutics worth $7.7M as of Q2 2026.
- Nordea Investment Management sold 50 United Therapeutics shares in Q2 2026, an estimated $28.2K.
- United Therapeutics made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #511 holding.
- Nordea Investment Management first reported a position in United Therapeutics in Q2 2015 and has held it in 30 quarters since.
- Nordea Investment Management's United Therapeutics position peaked at $86.2M in Q2 2024.
- 879 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.